MAPK8 and metabolic dysfunction-associated steatotic liver disease: Notably, JNK was aberrantly activated in patients with NAFLD, and this aberrant activation was accompanied with symptoms such as insulin resistance and inflammation (Hirosumi et al, 2002; Czaja, 2010).